CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 20  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1113
LYS 10.0228
GLU 20.0480
LEU 30.0134
ARG 40.0233
CYS 50.0216
GLN 60.0178
CYS 70.0187
ILE 80.0310
LYS 90.0275
THR 100.0158
TYR 110.0151
SER 120.0091
LYS 130.0224
PRO 140.0241
PHE 150.0146
HIS 160.0197
PRO 170.0150
LYS 180.0189
PHE 190.0156
ILE 200.0089
LYS 210.0144
GLU 220.0154
LEU 230.0066
ARG 240.0048
VAL 250.0107
ILE 260.0180
GLU 270.0303
SER 280.0267
GLY 290.0222
PRO 300.0197
HIS 310.0212
CYS 320.0195
ALA 330.0309
ASN 340.0204
THR 350.0206
GLU 360.0113
ILE 370.0088
ILE 380.0071
VAL 390.0013
LYS 400.0172
LEU 410.0157
SER 420.0200
ASP 430.0531
GLY 440.0517
ARG 450.0504
GLU 460.0218
LEU 470.0110
CYS 480.0127
LEU 490.0081
ASP 500.0095
PRO 510.0079
LYS 520.0219
GLU 530.0231
ASN 540.0313
TRP 550.0255
VAL 560.0139
GLN 570.0127
ARG 580.0147
VAL 590.0128
VAL 600.0120
GLU 610.0097
LYS 620.0113
PHE 630.0163
LEU 640.0180
LYS 650.0155
ARG 660.0236
ALA 670.0380
GLU 680.0613
ASN 690.1113

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.